Albemarle (ALB) Appoints Former Wyeth President Joseph Mahady to Board
Get Alerts ALB Hot Sheet
Price: $131.78 +2.31%
Overall Analyst Rating:
NEUTRAL ( Down)
Dividend Yield: 1.3%
EPS Growth %: -98.0%
Overall Analyst Rating:
NEUTRAL ( Down)
Dividend Yield: 1.3%
EPS Growth %: -98.0%
Join SI Premium – FREE
Albemarle Corporation (NYSE: ALB) announced today that its board of directors has elected Joseph M. Mahady to the company's board, effective February 1, 2012.
In 2009, Mahady retired from Wyeth Corporation, a global manufacturer of pharmaceutical products, following its acquisition by Pfizer (NYSE: PFE) and after 30 years with the company. At the time of his retirement, Mahady served as president – Wyeth Pharmaceuticals.
In 2009, Mahady retired from Wyeth Corporation, a global manufacturer of pharmaceutical products, following its acquisition by Pfizer (NYSE: PFE) and after 30 years with the company. At the time of his retirement, Mahady served as president – Wyeth Pharmaceuticals.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dyadic International, Inc. (DYAI) Announces Board and Management Changes
- Bowlero Corp (BOWL) Appoints Zac Sulma as Chief Sales Officer
- Nuvation Bio (NUVB) Appoints Colleen Sjogren as Chief Commercial Officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!